0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Liver Diseases Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: November 2024
|
Report Code: QYRE-Auto-3J6255
Home | Market Reports | Health| Health Conditions
Global Liver Diseases Treatment Market Insights and Forecast to 2028
BUY CHAPTERS

Liver Diseases Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-3J6255
Report
November 2024
Pages:159
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Liver Diseases Treatment - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Liver Diseases Treatment - Market

Liver Diseases Treatment - Market

Liver disease, greenish-yellow or greenish-brown skin, often due to intrahepatic cholestasis, intrahepatic or extrahepatic biliary obstruction.The sex hormone secreted in liver disease cannot degrade and inactivate in time, which leads to hyperemia and dilatation of superficial arterioles.
The global market for Liver Diseases Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Liver Diseases Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Liver Diseases Treatment by region & country, by Type, and by Application.
The Liver Diseases Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liver Diseases Treatment.
Market Segmentation

Scope of Liver Diseases Treatment - Market Report

Report Metric Details
Report Name Liver Diseases Treatment - Market
CAGR 5%
Segment by Type:
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott Laboratories, Bayer Schering, Eli Lilly, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Takeda Pharmaceutical, Zydus Pharmaceuticals, Glaxosmithkline, Bristol-Myers Squibb, General Electric, Koninklijke Philips, Siemens, Canon Medical Systems Corp, Hitachi, Elekta, Neusoft Corporation, Samsung Healthcare, BPL Medical Technologies, Cura Healthcare, Angion Biomedica, Achillion Pharmaceuticals, Gilead Sciences, LG Life Sciences, Verva Pharmaceuticals, Shenzhen Kangtai Biological Products, Raptor Pharmaceuticals, ProMetic Life Sciences, Phenex Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Liver Diseases Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Liver Diseases Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Liver Diseases Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Liver Diseases Treatment - Market report?

Ans: The main players in the Liver Diseases Treatment - Market are Abbott Laboratories, Bayer Schering, Eli Lilly, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Takeda Pharmaceutical, Zydus Pharmaceuticals, Glaxosmithkline, Bristol-Myers Squibb, General Electric, Koninklijke Philips, Siemens, Canon Medical Systems Corp, Hitachi, Elekta, Neusoft Corporation, Samsung Healthcare, BPL Medical Technologies, Cura Healthcare, Angion Biomedica, Achillion Pharmaceuticals, Gilead Sciences, LG Life Sciences, Verva Pharmaceuticals, Shenzhen Kangtai Biological Products, Raptor Pharmaceuticals, ProMetic Life Sciences, Phenex Pharmaceuticals

What are the Application segmentation covered in the Liver Diseases Treatment - Market report?

Ans: The Applications covered in the Liver Diseases Treatment - Market report are Cancer, Hepatitis, Cirrhosis, Other

What are the Type segmentation covered in the Liver Diseases Treatment - Market report?

Ans: The Types covered in the Liver Diseases Treatment - Market report are Chemotherapy Drugs, Targeted Therapy, Anti-Viral Drugs, Immunoglobulins, Corticosteroids, Vaccines, Anti-Rejection Drugs/Immunosuppressant

Recommended Reports

Liver Disease Treatments

Chronic Disease Therapy

General Disease Management

1 Market Overview
1.1 Liver Diseases Treatment Product Introduction
1.2 Global Liver Diseases Treatment Market Size Forecast
1.3 Liver Diseases Treatment Market Trends & Drivers
1.3.1 Liver Diseases Treatment Industry Trends
1.3.2 Liver Diseases Treatment Market Drivers & Opportunity
1.3.3 Liver Diseases Treatment Market Challenges
1.3.4 Liver Diseases Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Liver Diseases Treatment Players Revenue Ranking (2023)
2.2 Global Liver Diseases Treatment Revenue by Company (2019-2024)
2.3 Key Companies Liver Diseases Treatment Manufacturing Base Distribution and Headquarters
2.4 Key Companies Liver Diseases Treatment Product Offered
2.5 Key Companies Time to Begin Mass Production of Liver Diseases Treatment
2.6 Liver Diseases Treatment Market Competitive Analysis
2.6.1 Liver Diseases Treatment Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Liver Diseases Treatment Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Diseases Treatment as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Chemotherapy Drugs
3.1.2 Targeted Therapy
3.1.3 Anti-Viral Drugs
3.1.4 Immunoglobulins
3.1.5 Corticosteroids
3.1.6 Vaccines
3.1.7 Anti-Rejection Drugs/Immunosuppressant
3.2 Global Liver Diseases Treatment Sales Value by Type
3.2.1 Global Liver Diseases Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Liver Diseases Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Liver Diseases Treatment Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Cancer
4.1.2 Hepatitis
4.1.3 Cirrhosis
4.1.4 Other
4.2 Global Liver Diseases Treatment Sales Value by Application
4.2.1 Global Liver Diseases Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Liver Diseases Treatment Sales Value, by Application (2019-2030)
4.2.3 Global Liver Diseases Treatment Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Liver Diseases Treatment Sales Value by Region
5.1.1 Global Liver Diseases Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Liver Diseases Treatment Sales Value by Region (2019-2024)
5.1.3 Global Liver Diseases Treatment Sales Value by Region (2025-2030)
5.1.4 Global Liver Diseases Treatment Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Liver Diseases Treatment Sales Value, 2019-2030
5.2.2 North America Liver Diseases Treatment Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Liver Diseases Treatment Sales Value, 2019-2030
5.3.2 Europe Liver Diseases Treatment Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Liver Diseases Treatment Sales Value, 2019-2030
5.4.2 Asia Pacific Liver Diseases Treatment Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Liver Diseases Treatment Sales Value, 2019-2030
5.5.2 South America Liver Diseases Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Liver Diseases Treatment Sales Value, 2019-2030
5.6.2 Middle East & Africa Liver Diseases Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Liver Diseases Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Liver Diseases Treatment Sales Value
6.3 United States
6.3.1 United States Liver Diseases Treatment Sales Value, 2019-2030
6.3.2 United States Liver Diseases Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Liver Diseases Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Liver Diseases Treatment Sales Value, 2019-2030
6.4.2 Europe Liver Diseases Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Liver Diseases Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Liver Diseases Treatment Sales Value, 2019-2030
6.5.2 China Liver Diseases Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Liver Diseases Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Liver Diseases Treatment Sales Value, 2019-2030
6.6.2 Japan Liver Diseases Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Liver Diseases Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Liver Diseases Treatment Sales Value, 2019-2030
6.7.2 South Korea Liver Diseases Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Liver Diseases Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Liver Diseases Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Liver Diseases Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Liver Diseases Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Liver Diseases Treatment Sales Value, 2019-2030
6.9.2 India Liver Diseases Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Liver Diseases Treatment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Profile
7.1.2 Abbott Laboratories Main Business
7.1.3 Abbott Laboratories Liver Diseases Treatment Products, Services and Solutions
7.1.4 Abbott Laboratories Liver Diseases Treatment Revenue (US$ Million) & (2019-2024)
7.1.5 Abbott Laboratories Recent Developments
7.2 Bayer Schering
7.2.1 Bayer Schering Profile
7.2.2 Bayer Schering Main Business
7.2.3 Bayer Schering Liver Diseases Treatment Products, Services and Solutions
7.2.4 Bayer Schering Liver Diseases Treatment Revenue (US$ Million) & (2019-2024)
7.2.5 Bayer Schering Recent Developments
7.3 Eli Lilly
7.3.1 Eli Lilly Profile
7.3.2 Eli Lilly Main Business
7.3.3 Eli Lilly Liver Diseases Treatment Products, Services and Solutions
7.3.4 Eli Lilly Liver Diseases Treatment Revenue (US$ Million) & (2019-2024)
7.3.5 Merck Recent Developments
7.4 Merck
7.4.1 Merck Profile
7.4.2 Merck Main Business
7.4.3 Merck Liver Diseases Treatment Products, Services and Solutions
7.4.4 Merck Liver Diseases Treatment Revenue (US$ Million) & (2019-2024)
7.4.5 Merck Recent Developments
7.5 Novartis
7.5.1 Novartis Profile
7.5.2 Novartis Main Business
7.5.3 Novartis Liver Diseases Treatment Products, Services and Solutions
7.5.4 Novartis Liver Diseases Treatment Revenue (US$ Million) & (2019-2024)
7.5.5 Novartis Recent Developments
7.6 Pfizer
7.6.1 Pfizer Profile
7.6.2 Pfizer Main Business
7.6.3 Pfizer Liver Diseases Treatment Products, Services and Solutions
7.6.4 Pfizer Liver Diseases Treatment Revenue (US$ Million) & (2019-2024)
7.6.5 Pfizer Recent Developments
7.7 Roche
7.7.1 Roche Profile
7.7.2 Roche Main Business
7.7.3 Roche Liver Diseases Treatment Products, Services and Solutions
7.7.4 Roche Liver Diseases Treatment Revenue (US$ Million) & (2019-2024)
7.7.5 Roche Recent Developments
7.8 Sanofi-Aventis
7.8.1 Sanofi-Aventis Profile
7.8.2 Sanofi-Aventis Main Business
7.8.3 Sanofi-Aventis Liver Diseases Treatment Products, Services and Solutions
7.8.4 Sanofi-Aventis Liver Diseases Treatment Revenue (US$ Million) & (2019-2024)
7.8.5 Sanofi-Aventis Recent Developments
7.9 Takeda Pharmaceutical
7.9.1 Takeda Pharmaceutical Profile
7.9.2 Takeda Pharmaceutical Main Business
7.9.3 Takeda Pharmaceutical Liver Diseases Treatment Products, Services and Solutions
7.9.4 Takeda Pharmaceutical Liver Diseases Treatment Revenue (US$ Million) & (2019-2024)
7.9.5 Takeda Pharmaceutical Recent Developments
7.10 Zydus Pharmaceuticals
7.10.1 Zydus Pharmaceuticals Profile
7.10.2 Zydus Pharmaceuticals Main Business
7.10.3 Zydus Pharmaceuticals Liver Diseases Treatment Products, Services and Solutions
7.10.4 Zydus Pharmaceuticals Liver Diseases Treatment Revenue (US$ Million) & (2019-2024)
7.10.5 Zydus Pharmaceuticals Recent Developments
7.11 Glaxosmithkline
7.11.1 Glaxosmithkline Profile
7.11.2 Glaxosmithkline Main Business
7.11.3 Glaxosmithkline Liver Diseases Treatment Products, Services and Solutions
7.11.4 Glaxosmithkline Liver Diseases Treatment Revenue (US$ Million) & (2019-2024)
7.11.5 Glaxosmithkline Recent Developments
7.12 Bristol-Myers Squibb
7.12.1 Bristol-Myers Squibb Profile
7.12.2 Bristol-Myers Squibb Main Business
7.12.3 Bristol-Myers Squibb Liver Diseases Treatment Products, Services and Solutions
7.12.4 Bristol-Myers Squibb Liver Diseases Treatment Revenue (US$ Million) & (2019-2024)
7.12.5 Bristol-Myers Squibb Recent Developments
7.13 General Electric
7.13.1 General Electric Profile
7.13.2 General Electric Main Business
7.13.3 General Electric Liver Diseases Treatment Products, Services and Solutions
7.13.4 General Electric Liver Diseases Treatment Revenue (US$ Million) & (2019-2024)
7.13.5 General Electric Recent Developments
7.14 Koninklijke Philips
7.14.1 Koninklijke Philips Profile
7.14.2 Koninklijke Philips Main Business
7.14.3 Koninklijke Philips Liver Diseases Treatment Products, Services and Solutions
7.14.4 Koninklijke Philips Liver Diseases Treatment Revenue (US$ Million) & (2019-2024)
7.14.5 Koninklijke Philips Recent Developments
7.15 Siemens
7.15.1 Siemens Profile
7.15.2 Siemens Main Business
7.15.3 Siemens Liver Diseases Treatment Products, Services and Solutions
7.15.4 Siemens Liver Diseases Treatment Revenue (US$ Million) & (2019-2024)
7.15.5 Siemens Recent Developments
7.16 Canon Medical Systems Corp
7.16.1 Canon Medical Systems Corp Profile
7.16.2 Canon Medical Systems Corp Main Business
7.16.3 Canon Medical Systems Corp Liver Diseases Treatment Products, Services and Solutions
7.16.4 Canon Medical Systems Corp Liver Diseases Treatment Revenue (US$ Million) & (2019-2024)
7.16.5 Canon Medical Systems Corp Recent Developments
7.17 Hitachi
7.17.1 Hitachi Profile
7.17.2 Hitachi Main Business
7.17.3 Hitachi Liver Diseases Treatment Products, Services and Solutions
7.17.4 Hitachi Liver Diseases Treatment Revenue (US$ Million) & (2019-2024)
7.17.5 Hitachi Recent Developments
7.18 Elekta
7.18.1 Elekta Profile
7.18.2 Elekta Main Business
7.18.3 Elekta Liver Diseases Treatment Products, Services and Solutions
7.18.4 Elekta Liver Diseases Treatment Revenue (US$ Million) & (2019-2024)
7.18.5 Elekta Recent Developments
7.19 Neusoft Corporation
7.19.1 Neusoft Corporation Profile
7.19.2 Neusoft Corporation Main Business
7.19.3 Neusoft Corporation Liver Diseases Treatment Products, Services and Solutions
7.19.4 Neusoft Corporation Liver Diseases Treatment Revenue (US$ Million) & (2019-2024)
7.19.5 Neusoft Corporation Recent Developments
7.20 Samsung Healthcare
7.20.1 Samsung Healthcare Profile
7.20.2 Samsung Healthcare Main Business
7.20.3 Samsung Healthcare Liver Diseases Treatment Products, Services and Solutions
7.20.4 Samsung Healthcare Liver Diseases Treatment Revenue (US$ Million) & (2019-2024)
7.20.5 Samsung Healthcare Recent Developments
7.21 BPL Medical Technologies
7.21.1 BPL Medical Technologies Profile
7.21.2 BPL Medical Technologies Main Business
7.21.3 BPL Medical Technologies Liver Diseases Treatment Products, Services and Solutions
7.21.4 BPL Medical Technologies Liver Diseases Treatment Revenue (US$ Million) & (2019-2024)
7.21.5 BPL Medical Technologies Recent Developments
7.22 Cura Healthcare
7.22.1 Cura Healthcare Profile
7.22.2 Cura Healthcare Main Business
7.22.3 Cura Healthcare Liver Diseases Treatment Products, Services and Solutions
7.22.4 Cura Healthcare Liver Diseases Treatment Revenue (US$ Million) & (2019-2024)
7.22.5 Cura Healthcare Recent Developments
7.23 Angion Biomedica
7.23.1 Angion Biomedica Profile
7.23.2 Angion Biomedica Main Business
7.23.3 Angion Biomedica Liver Diseases Treatment Products, Services and Solutions
7.23.4 Angion Biomedica Liver Diseases Treatment Revenue (US$ Million) & (2019-2024)
7.23.5 Angion Biomedica Recent Developments
7.24 Achillion Pharmaceuticals
7.24.1 Achillion Pharmaceuticals Profile
7.24.2 Achillion Pharmaceuticals Main Business
7.24.3 Achillion Pharmaceuticals Liver Diseases Treatment Products, Services and Solutions
7.24.4 Achillion Pharmaceuticals Liver Diseases Treatment Revenue (US$ Million) & (2019-2024)
7.24.5 Achillion Pharmaceuticals Recent Developments
7.25 Gilead Sciences
7.25.1 Gilead Sciences Profile
7.25.2 Gilead Sciences Main Business
7.25.3 Gilead Sciences Liver Diseases Treatment Products, Services and Solutions
7.25.4 Gilead Sciences Liver Diseases Treatment Revenue (US$ Million) & (2019-2024)
7.25.5 Gilead Sciences Recent Developments
7.26 LG Life Sciences
7.26.1 LG Life Sciences Profile
7.26.2 LG Life Sciences Main Business
7.26.3 LG Life Sciences Liver Diseases Treatment Products, Services and Solutions
7.26.4 LG Life Sciences Liver Diseases Treatment Revenue (US$ Million) & (2019-2024)
7.26.5 LG Life Sciences Recent Developments
7.27 Verva Pharmaceuticals
7.27.1 Verva Pharmaceuticals Profile
7.27.2 Verva Pharmaceuticals Main Business
7.27.3 Verva Pharmaceuticals Liver Diseases Treatment Products, Services and Solutions
7.27.4 Verva Pharmaceuticals Liver Diseases Treatment Revenue (US$ Million) & (2019-2024)
7.27.5 Verva Pharmaceuticals Recent Developments
7.28 Shenzhen Kangtai Biological Products
7.28.1 Shenzhen Kangtai Biological Products Profile
7.28.2 Shenzhen Kangtai Biological Products Main Business
7.28.3 Shenzhen Kangtai Biological Products Liver Diseases Treatment Products, Services and Solutions
7.28.4 Shenzhen Kangtai Biological Products Liver Diseases Treatment Revenue (US$ Million) & (2019-2024)
7.28.5 Shenzhen Kangtai Biological Products Recent Developments
7.29 Raptor Pharmaceuticals
7.29.1 Raptor Pharmaceuticals Profile
7.29.2 Raptor Pharmaceuticals Main Business
7.29.3 Raptor Pharmaceuticals Liver Diseases Treatment Products, Services and Solutions
7.29.4 Raptor Pharmaceuticals Liver Diseases Treatment Revenue (US$ Million) & (2019-2024)
7.29.5 Raptor Pharmaceuticals Recent Developments
7.30 ProMetic Life Sciences
7.30.1 ProMetic Life Sciences Profile
7.30.2 ProMetic Life Sciences Main Business
7.30.3 ProMetic Life Sciences Liver Diseases Treatment Products, Services and Solutions
7.30.4 ProMetic Life Sciences Liver Diseases Treatment Revenue (US$ Million) & (2019-2024)
7.30.5 ProMetic Life Sciences Recent Developments
7.31 Phenex Pharmaceuticals
7.31.1 Phenex Pharmaceuticals Profile
7.31.2 Phenex Pharmaceuticals Main Business
7.31.3 Phenex Pharmaceuticals Liver Diseases Treatment Products, Services and Solutions
7.31.4 Phenex Pharmaceuticals Liver Diseases Treatment Revenue (US$ Million) & (2019-2024)
7.31.5 Phenex Pharmaceuticals Recent Developments
8 Industry Chain Analysis
8.1 Liver Diseases Treatment Industrial Chain
8.2 Liver Diseases Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Liver Diseases Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Liver Diseases Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Liver Diseases Treatment Market Trends
    Table 2. Liver Diseases Treatment Market Drivers & Opportunity
    Table 3. Liver Diseases Treatment Market Challenges
    Table 4. Liver Diseases Treatment Market Restraints
    Table 5. Global Liver Diseases Treatment Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Liver Diseases Treatment Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Liver Diseases Treatment Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Liver Diseases Treatment Product Type
    Table 9. Key Companies Time to Begin Mass Production of Liver Diseases Treatment
    Table 10. Global Liver Diseases Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Diseases Treatment as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Liver Diseases Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Liver Diseases Treatment Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Liver Diseases Treatment Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Liver Diseases Treatment Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Liver Diseases Treatment Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Liver Diseases Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Liver Diseases Treatment Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Liver Diseases Treatment Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Liver Diseases Treatment Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Liver Diseases Treatment Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Liver Diseases Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Liver Diseases Treatment Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Liver Diseases Treatment Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Liver Diseases Treatment Sales Value by Region (2019-2024) & (%)
    Table 27. Global Liver Diseases Treatment Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Liver Diseases Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Liver Diseases Treatment Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Liver Diseases Treatment Sales Value, (2025-2030) & (US$ Million)
    Table 31. Abbott Laboratories Basic Information List
    Table 32. Abbott Laboratories Description and Business Overview
    Table 33. Abbott Laboratories Liver Diseases Treatment Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Liver Diseases Treatment Business of Abbott Laboratories (2019-2024)
    Table 35. Abbott Laboratories Recent Developments
    Table 36. Bayer Schering Basic Information List
    Table 37. Bayer Schering Description and Business Overview
    Table 38. Bayer Schering Liver Diseases Treatment Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Liver Diseases Treatment Business of Bayer Schering (2019-2024)
    Table 40. Bayer Schering Recent Developments
    Table 41. Eli Lilly Basic Information List
    Table 42. Eli Lilly Description and Business Overview
    Table 43. Eli Lilly Liver Diseases Treatment Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Liver Diseases Treatment Business of Eli Lilly (2019-2024)
    Table 45. Eli Lilly Recent Developments
    Table 46. Merck Basic Information List
    Table 47. Merck Description and Business Overview
    Table 48. Merck Liver Diseases Treatment Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Liver Diseases Treatment Business of Merck (2019-2024)
    Table 50. Merck Recent Developments
    Table 51. Novartis Basic Information List
    Table 52. Novartis Description and Business Overview
    Table 53. Novartis Liver Diseases Treatment Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Liver Diseases Treatment Business of Novartis (2019-2024)
    Table 55. Novartis Recent Developments
    Table 56. Pfizer Basic Information List
    Table 57. Pfizer Description and Business Overview
    Table 58. Pfizer Liver Diseases Treatment Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Liver Diseases Treatment Business of Pfizer (2019-2024)
    Table 60. Pfizer Recent Developments
    Table 61. Roche Basic Information List
    Table 62. Roche Description and Business Overview
    Table 63. Roche Liver Diseases Treatment Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Liver Diseases Treatment Business of Roche (2019-2024)
    Table 65. Roche Recent Developments
    Table 66. Sanofi-Aventis Basic Information List
    Table 67. Sanofi-Aventis Description and Business Overview
    Table 68. Sanofi-Aventis Liver Diseases Treatment Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Liver Diseases Treatment Business of Sanofi-Aventis (2019-2024)
    Table 70. Sanofi-Aventis Recent Developments
    Table 71. Takeda Pharmaceutical Basic Information List
    Table 72. Takeda Pharmaceutical Description and Business Overview
    Table 73. Takeda Pharmaceutical Liver Diseases Treatment Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Liver Diseases Treatment Business of Takeda Pharmaceutical (2019-2024)
    Table 75. Takeda Pharmaceutical Recent Developments
    Table 76. Zydus Pharmaceuticals Basic Information List
    Table 77. Zydus Pharmaceuticals Description and Business Overview
    Table 78. Zydus Pharmaceuticals Liver Diseases Treatment Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Liver Diseases Treatment Business of Zydus Pharmaceuticals (2019-2024)
    Table 80. Zydus Pharmaceuticals Recent Developments
    Table 81. Glaxosmithkline Basic Information List
    Table 82. Glaxosmithkline Description and Business Overview
    Table 83. Glaxosmithkline Liver Diseases Treatment Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Liver Diseases Treatment Business of Glaxosmithkline (2019-2024)
    Table 85. Glaxosmithkline Recent Developments
    Table 86. Bristol-Myers Squibb Basic Information List
    Table 87. Bristol-Myers Squibb Description and Business Overview
    Table 88. Bristol-Myers Squibb Liver Diseases Treatment Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Liver Diseases Treatment Business of Bristol-Myers Squibb (2019-2024)
    Table 90. Bristol-Myers Squibb Recent Developments
    Table 91. General Electric Basic Information List
    Table 92. General Electric Description and Business Overview
    Table 93. General Electric Liver Diseases Treatment Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Liver Diseases Treatment Business of General Electric (2019-2024)
    Table 95. General Electric Recent Developments
    Table 96. Koninklijke Philips Basic Information List
    Table 97. Koninklijke Philips Description and Business Overview
    Table 98. Koninklijke Philips Liver Diseases Treatment Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Liver Diseases Treatment Business of Koninklijke Philips (2019-2024)
    Table 100. Koninklijke Philips Recent Developments
    Table 101. Siemens Basic Information List
    Table 102. Siemens Description and Business Overview
    Table 103. Siemens Liver Diseases Treatment Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Liver Diseases Treatment Business of Siemens (2019-2024)
    Table 105. Siemens Recent Developments
    Table 106. Canon Medical Systems Corp Basic Information List
    Table 107. Canon Medical Systems Corp Description and Business Overview
    Table 108. Canon Medical Systems Corp Liver Diseases Treatment Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Liver Diseases Treatment Business of Canon Medical Systems Corp (2019-2024)
    Table 110. Canon Medical Systems Corp Recent Developments
    Table 111. Hitachi Basic Information List
    Table 112. Hitachi Description and Business Overview
    Table 113. Hitachi Liver Diseases Treatment Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Liver Diseases Treatment Business of Hitachi (2019-2024)
    Table 115. Hitachi Recent Developments
    Table 116. Elekta Basic Information List
    Table 117. Elekta Description and Business Overview
    Table 118. Elekta Liver Diseases Treatment Products, Services and Solutions
    Table 119. Revenue (US$ Million) in Liver Diseases Treatment Business of Elekta (2019-2024)
    Table 120. Elekta Recent Developments
    Table 121. Neusoft Corporation Basic Information List
    Table 122. Neusoft Corporation Description and Business Overview
    Table 123. Neusoft Corporation Liver Diseases Treatment Products, Services and Solutions
    Table 124. Revenue (US$ Million) in Liver Diseases Treatment Business of Neusoft Corporation (2019-2024)
    Table 125. Neusoft Corporation Recent Developments
    Table 126. Samsung Healthcare Basic Information List
    Table 127. Samsung Healthcare Description and Business Overview
    Table 128. Samsung Healthcare Liver Diseases Treatment Products, Services and Solutions
    Table 129. Revenue (US$ Million) in Liver Diseases Treatment Business of Samsung Healthcare (2019-2024)
    Table 130. Samsung Healthcare Recent Developments
    Table 131. BPL Medical Technologies Basic Information List
    Table 132. BPL Medical Technologies Description and Business Overview
    Table 133. BPL Medical Technologies Liver Diseases Treatment Products, Services and Solutions
    Table 134. Revenue (US$ Million) in Liver Diseases Treatment Business of BPL Medical Technologies (2019-2024)
    Table 135. BPL Medical Technologies Recent Developments
    Table 136. Cura Healthcare Basic Information List
    Table 137. Cura Healthcare Description and Business Overview
    Table 138. Cura Healthcare Liver Diseases Treatment Products, Services and Solutions
    Table 139. Revenue (US$ Million) in Liver Diseases Treatment Business of Cura Healthcare (2019-2024)
    Table 140. Cura Healthcare Recent Developments
    Table 141. Angion Biomedica Basic Information List
    Table 142. Angion Biomedica Description and Business Overview
    Table 143. Angion Biomedica Liver Diseases Treatment Products, Services and Solutions
    Table 144. Revenue (US$ Million) in Liver Diseases Treatment Business of Angion Biomedica (2019-2024)
    Table 145. Angion Biomedica Recent Developments
    Table 146. Achillion Pharmaceuticals Basic Information List
    Table 147. Achillion Pharmaceuticals Description and Business Overview
    Table 148. Achillion Pharmaceuticals Liver Diseases Treatment Products, Services and Solutions
    Table 149. Revenue (US$ Million) in Liver Diseases Treatment Business of Achillion Pharmaceuticals (2019-2024)
    Table 150. Achillion Pharmaceuticals Recent Developments
    Table 151. Gilead Sciences Basic Information List
    Table 152. Gilead Sciences Description and Business Overview
    Table 153. Gilead Sciences Liver Diseases Treatment Products, Services and Solutions
    Table 154. Revenue (US$ Million) in Liver Diseases Treatment Business of Gilead Sciences (2019-2024)
    Table 155. Gilead Sciences Recent Developments
    Table 156. LG Life Sciences Basic Information List
    Table 157. LG Life Sciences Description and Business Overview
    Table 158. LG Life Sciences Liver Diseases Treatment Products, Services and Solutions
    Table 159. Revenue (US$ Million) in Liver Diseases Treatment Business of LG Life Sciences (2019-2024)
    Table 160. LG Life Sciences Recent Developments
    Table 161. Verva Pharmaceuticals Basic Information List
    Table 162. Verva Pharmaceuticals Description and Business Overview
    Table 163. Verva Pharmaceuticals Liver Diseases Treatment Products, Services and Solutions
    Table 164. Revenue (US$ Million) in Liver Diseases Treatment Business of Verva Pharmaceuticals (2019-2024)
    Table 165. Verva Pharmaceuticals Recent Developments
    Table 166. Shenzhen Kangtai Biological Products Basic Information List
    Table 167. Shenzhen Kangtai Biological Products Description and Business Overview
    Table 168. Shenzhen Kangtai Biological Products Liver Diseases Treatment Products, Services and Solutions
    Table 169. Revenue (US$ Million) in Liver Diseases Treatment Business of Shenzhen Kangtai Biological Products (2019-2024)
    Table 170. Shenzhen Kangtai Biological Products Recent Developments
    Table 171. Raptor Pharmaceuticals Basic Information List
    Table 172. Raptor Pharmaceuticals Description and Business Overview
    Table 173. Raptor Pharmaceuticals Liver Diseases Treatment Products, Services and Solutions
    Table 174. Revenue (US$ Million) in Liver Diseases Treatment Business of Raptor Pharmaceuticals (2019-2024)
    Table 175. Raptor Pharmaceuticals Recent Developments
    Table 176. ProMetic Life Sciences Basic Information List
    Table 177. ProMetic Life Sciences Description and Business Overview
    Table 178. ProMetic Life Sciences Liver Diseases Treatment Products, Services and Solutions
    Table 179. Revenue (US$ Million) in Liver Diseases Treatment Business of ProMetic Life Sciences (2019-2024)
    Table 180. ProMetic Life Sciences Recent Developments
    Table 181. Phenex Pharmaceuticals Basic Information List
    Table 182. Phenex Pharmaceuticals Description and Business Overview
    Table 183. Phenex Pharmaceuticals Liver Diseases Treatment Products, Services and Solutions
    Table 184. Revenue (US$ Million) in Liver Diseases Treatment Business of Phenex Pharmaceuticals (2019-2024)
    Table 185. Phenex Pharmaceuticals Recent Developments
    Table 186. Key Raw Materials Lists
    Table 187. Raw Materials Key Suppliers Lists
    Table 188. Liver Diseases Treatment Downstream Customers
    Table 189. Liver Diseases Treatment Distributors List
    Table 190. Research Programs/Design for This Report
    Table 191. Key Data Information from Secondary Sources
    Table 192. Key Data Information from Primary Sources
    Table 193. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Liver Diseases Treatment Product Picture
    Figure 2. Global Liver Diseases Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Liver Diseases Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 4. Liver Diseases Treatment Report Years Considered
    Figure 5. Global Liver Diseases Treatment Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Liver Diseases Treatment Revenue in 2023
    Figure 7. Liver Diseases Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Chemotherapy Drugs Picture
    Figure 9. Targeted Therapy Picture
    Figure 10. Anti-Viral Drugs Picture
    Figure 11. Immunoglobulins Picture
    Figure 12. Corticosteroids Picture
    Figure 13. Vaccines Picture
    Figure 14. Anti-Rejection Drugs/Immunosuppressant Picture
    Figure 15. Global Liver Diseases Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Liver Diseases Treatment Sales Value Market Share by Type, 2023 & 2030
    Figure 17. Product Picture of Cancer
    Figure 18. Product Picture of Hepatitis
    Figure 19. Product Picture of Cirrhosis
    Figure 20. Product Picture of Other
    Figure 21. Global Liver Diseases Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Liver Diseases Treatment Sales Value Market Share by Application, 2023 & 2030
    Figure 23. North America Liver Diseases Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 24. North America Liver Diseases Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 25. Europe Liver Diseases Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 26. Europe Liver Diseases Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 27. Asia Pacific Liver Diseases Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 28. Asia Pacific Liver Diseases Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 29. South America Liver Diseases Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 30. South America Liver Diseases Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 31. Middle East & Africa Liver Diseases Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 32. Middle East & Africa Liver Diseases Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 33. Key Countries/Regions Liver Diseases Treatment Sales Value (%), (2019-2030)
    Figure 34. United States Liver Diseases Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 35. United States Liver Diseases Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 36. United States Liver Diseases Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 37. Europe Liver Diseases Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Europe Liver Diseases Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 39. Europe Liver Diseases Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 40. China Liver Diseases Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 41. China Liver Diseases Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 42. China Liver Diseases Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 43. Japan Liver Diseases Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Japan Liver Diseases Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 45. Japan Liver Diseases Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 46. South Korea Liver Diseases Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 47. South Korea Liver Diseases Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 48. South Korea Liver Diseases Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 49. Southeast Asia Liver Diseases Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 50. Southeast Asia Liver Diseases Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 51. Southeast Asia Liver Diseases Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 52. India Liver Diseases Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 53. India Liver Diseases Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 54. India Liver Diseases Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 55. Liver Diseases Treatment Industrial Chain
    Figure 56. Liver Diseases Treatment Manufacturing Cost Structure
    Figure 57. Channels of Distribution (Direct Sales, and Distribution)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

RELATED REPORTS

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32P14840
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Digital Platform for Chronic Kidney Disease (CKD) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20V18395
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Continuous Glucose Monitoring Sensor Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32G20014
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Radioactive Iodine Ablation Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9U20281
Tue Dec 02 00:00:00 UTC 2025

Add to Cart